As the logistics experts of the pharmaceutical supply chain, distributors have developed advanced security and monitoring systems to make sure that the medications they handle and transport are authentic and legitimate; secured throughout delivery to avoid tampering or diversion; and received by licensed pharmacies and healthcare providers across the country.
The Healthcare Distribution Alliance (HDA) issued a statement in response to the Minnesota Senate’s passage of HF 400, which imposes annual fees on prescription opioid manufacturers and distributors.
Today, the Healthcare Distribution Alliance (HDA) announced the launch of a new initiative highlighting pharmaceutical distributors’ critical role in the safe, reliable and efficient delivery of medical products to hundreds of thousands of pharmacies, hospitals and other healthcare providers nationwide. The initiative focuses on the work distributors undertake every day, even during the most challenging times, in collaboration with partners across the pharmaceutical supply chain.
HDA’s Pharmaceutical Cargo Security Coalition (PCSC) recognized three security professionals for their dedication to the industry today at the PCSC Educational Seminar in East Hanover, N.J. The PCSC Award acknowledges leaders who have exhibited extraordinary standards of honesty and integrity while working tirelessly to protect and serve their communities.
Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to the passage of the New York state budget, which includes an annual excise tax on prescription opioid manufacturers and distributors.
John Parker
(703) 885-0216
Farah Simonett
(703) 885-0269
